MedTrace Logo

Electronic Nose and Fetal Chromosomal Disorders

NCT02579213 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-10-19

No results posted yet for this study

Summary

"electronic nose"- the tiny sensors, will smell and detect the changes in the sample of abnormal fetal karyotype, and fluid that will be confirmed by amniocentesis.

Conditions

  • Detecting Abnormal Fetal Karyotype by the Electronic Nose

Interventions

OTHER

observational study done only in women candidate for amniocentesis

As a part of routine test in women with obstetrical indication for amniocentesis, we take 30 cc of amniotic fluid. only additional 3 ml of the amniotic fluid are needed for examination by electronic sensors.

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579213 on ClinicalTrials.gov